Disclaimer: This article is intended solely for informational and educational purposes only. It does not constitute medical advice.
Historically, anesthesiologists relied on heart rate, blood pressure, and limb movement to infer depth of anesthesia, yet these clinical surrogates suffer from poor specificity and sensitivity, leaving patients at risk of both under- and over-dosing (Gu et al., 2024). The Bispectral Index (BIS) was developed in an attempt to address this gap and applies proprietary bispectral analysis to the frontal electroencephalogram, compressing the raw signal into a single dimensionless value between 0 (cortical silence) and 100 (fully awake), with 40–60 generally considered appropriate for surgical anesthesia (Hajat, Ahmad, & Andrzejowski, 2017).
Because BIS is derived directly from cortical electrical activity rather than autonomic reflexes, it theoretically offers a more direct window into hypnotic state, and validation work has found supporting evidence in both adult and pediatric patients that BIS values at induction, maintenance, and emergence correlate predictably with end-tidal sevoflurane concentration (Denman et al., 2000). However, criticism of BIS monitoring persists, particularly of data that show no benefit in some important postoperative outcomes and that question the precision of the proprietary algorithm.
The clinical case for BIS is largely informed by the B-Aware trial, in which BIS-guided anesthesia reduced confirmed intraoperative awareness by 82% in high-risk surgical patients, at a modest cost of roughly $2,200 per case prevented (Myles, Leslie, McNeil, Forbes, & Chan, 2004). A subsequent large trial using BIS during total intravenous anesthesia similarly reported a marked reduction in awareness compared with a BIS-blinded cohort (Jin, Feldman, & Gan, 2019). A 2024 systematic review and meta-analysis of 40 randomized trials concluded that BIS showed recovery-related benefits, finding significant reductions in postoperative cognitive dysfunction, eye-opening time, orientation recovery time, extubation time, PACU stay, and overall anesthetic dosage compared with conventional monitoring (Gu et al., 2024).
These benefits, however, are accompanied by substantial and often unresolved criticism of BIS monitoring. The same 2024 meta-analysis found no significant reduction in postoperative delirium, nausea and vomiting, abnormal blood pressure, mortality, or, notably, intraoperative awareness itself when pooled across all 14 eligible trials—an outcome at odds with BIS’s core rationale (Gu et al., 2024). Heterogeneity across these pooled estimates was frequently high, and analysis identified some bias for eye-opening time, extubation time, and PACU stay, raising questions about the robustness of the recovery-time findings (Gu et al., 2024). Larger multicenter trials comparing BIS with end-tidal anesthetic gas monitoring, including B-Unaware and BAG-RECALL, likewise failed to show a significant awareness benefit for BIS, suggesting that maintaining a minimum alveolar concentration above 0.7 may be equally effective (Hajat et al., 2017).
BIS also carries technical vulnerabilities that complicate its interpretation. The algorithm incorporates frontalis electromyographic activity, so neuromuscular blockade, its reversal, and painful or stimulating events can all shift BIS values independent of true hypnotic depth; ketamine, dexmedetomidine, and xenon each distort the number in agent-specific ways (Hajat et al., 2017). Isolated forearm technique studies have repeatedly shown that patients can respond to command at BIS values within or even below the recommended 40–60 range, suggesting that BIS functions better as a “recall probability” monitor than a true awareness monitor (Hajat et al., 2017). Current data have not led to an endorsement of BIS monitoring as an unqualified standard of care, with its adoption remaining largely facility-dependent, and further evidence would be needed to sway guidelines and assuage criticism (Hajat et al., 2017; Jin et al., 2019).
References
- Denman, W. T., Swanson, E. L., Rosow, D., Ezbicki, K., Connors, P. D., & Rosow, C. E. (2000). Pediatric evaluation of the bispectral index (BIS) monitor and correlation of BIS with end-tidal sevoflurane concentration in infants and children. Anesthesia & Analgesia, 90(4), 872–877. https://doi.org/10.1097/00000539-200004000-00018
- Gu, Y., Hao, J., Wang, J., Liang, P., Peng, X., Qin, X., Zhang, Y., & He, D. (2024). Effectiveness assessment of bispectral index monitoring compared with conventional monitoring in general anesthesia: A systematic review and meta-analysis. Anesthesiology Research and Practice, 2024, Article 5555481. https://doi.org/10.1155/2024/5555481
- Hajat, Z., Ahmad, N., & Andrzejowski, J. (2017). The role and limitations of EEG-based depth of anaesthesia monitoring in theatres and intensive care. Anaesthesia, 72(Suppl. 1), 38–47. https://doi.org/10.1111/anae.13739
- Jin, Z., Feldman, J., & Gan, T. J. (2019). Depth of anesthesia monitoring—Why not a standard of care? APSF Newsletter, 34(2), 43–44. https://www.apsf.org/article/depth-of-anesthesia-monitoring-why-not-a-standard-of-care/
- Myles, P. S., Leslie, K., McNeil, J., Forbes, A., & Chan, M. T. V. (2004). Bispectral index monitoring to prevent awareness during anaesthesia: The B-Aware randomised controlled trial. The Lancet, 363(9423), 1757–1763. https://doi.org/10.1016/S0140-6736(04)16300-9